Back to Results
First PageMeta Content



Mirror, Mirror on the Wall: Medicare Part D pays needlessly high brand-name drug prices compared with other OECD countries and with U.S. government programs By Marc-André Gagnon, PhD.
Add to Reading List

Document Date: 2015-07-23 16:05:58


Open Document

File Size: 489,22 KB

Share Result on Facebook
UPDATE